Issue of Equity

Issue of Equity

Eco Animal Health Group Plc

5 October 2012

Eco Animal Health Group plc ("Eco" or the "Company")

The Company announces that on 5 October 2012, 16,575 new Ordinary shares of 5p each were issued to shareholders who elected to receive new shares instead of cash for the interim dividend declared by the directors on 19 July 2012 and who held Ordinary shares on the record date of 31 August 2012. The new shares, which will rank pari passu with the existing shares of the Company, are expected to be admitted to trading on 9 October 2012.

Following these issues, the Company has 55,135,776 shares in issue and the directors have the following shareholdings:

	Â	Number of Shares held prior to scrip	Â	Shareholding post scrip	Â	Percentage shareholding post scrip
							Â
P Lawrence & family		11,208,536		11,208,536		20.33
Executive Chairman
							Â
K Stockdale		8,051		8,051		0.02
Finance Director
							Â
B Clemo		7,972		7,972		0.02
Executive Director
							Â
J Trouse		3,300		3,300		0.01
Executive Director
							Â
D Danson		14,598		14,598		0.02
Non Executive Director

Enquires:

Eco Animal Health Group plc	Â
Peter Lawrence, Executive Chairman		020 8336 6190

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products. Our products for these global growth markets promote well-being in animals. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.